Corporate calendar for BridgeBio Pharma, Inc. (BBIO): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
BridgeBio Pharma, Inc. is a pharmaceutical company dedicated to identifying, advancing, and providing medical solutions for various genetic conditions. The firm boasts an extensive portfolio comprising 30 distinct development initiatives, spanning the entire spectrum from initial discovery research to advanced clinical trial phases.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-10-28 | $-0.61 | $269M |
| 2026-08-10 | $-0.58 | $221M |
| 2026-05-07 | $-0.68 | $178M |
| 2026-02-24 | $-0.71 | $147M |
| 2025-10-29 | $-0.88 | $148M |
| 2025-08-05 | $-0.83 | $108M |
| 2025-04-29 | $-1.00 | $68M |
Price
| Price | $66.14 |
| Market Cap | $13.0B |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 24 |
| Hold | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 27 |
| Avg rating (1-5) | 0.89 |
Related companies: ASND · BMRN · EXEL · IONS · JAZZ · MRNA · RNA
Explore sector: Healthcare · Biotechnology
More sections of BBIO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks